Light-emitting nanoprobes can detect cancer early and track the spread of tiny tumors
Using light-emitting nanoparticles, Rutgers University-New Brunswick scientists have invented a highly effective method to detect tiny tumors and track their spread, potentially leading to earlier cancer detection and more precise treatment.
The technology, announced today, could improve patient cure rates and survival times.
“We’ve always had this dream that we can track the progression of cancer in real time, and that’s what we’ve done here,” said Prabhas V. Moghe, a corresponding author of the study and distinguished professor of biomedical engineering and chemical and biochemical engineering at Rutgers–New Brunswick. “We’ve tracked the disease in its very incipient stages.”
The study, published online today in Nature Biomedical Engineering, shows that the new method is better than magnetic resonance imaging (MRI) and other cancer surveillance technologies. The research team included Rutgers’ flagship research institution (Rutgers University-New Brunswick) and its academic health center (Rutgers Biomedical and Health Sciences, or RBHS).
“The Achilles’ heel of surgical management for cancer is the presence of micro metastases. This is also a problem for proper staging or treatment planning. The nanoprobes described in this paper will go a long way to solving these problems,” said Dr. Steven K. Libutti, director of Rutgers Cancer Institute of New Jersey. He is senior vice president of oncology services for RWJBarnabas Health and vice chancellor for cancer programs for Rutgers Biomedical and Health Sciences.
The ability to spot early tumors that are starting to spread remains a major challenge in cancer diagnosis and treatment, as most imaging methods fail to detect small cancerous lesions. But the Rutgers study shows that tiny tumors in mice can be detected with the injection of nanoprobes, which are microscopic optical devices, that emit short-wave infrared light as they travel through the bloodstream – even tracking tiny tumors in multiple organs.
The nanoprobes were significantly faster than MRIs at detecting the minute spread of tiny lesions and tumors in the adrenal glands and bones in mice. That would likely translate to detection months earlier in people, potentially resulting in saved lives, said Vidya Ganapathy, a corresponding author and assistant research professor in the Department of Biomedical Engineering.
“Cancer cells can lodge in different niches in the body, and the probe follows the spreading cells wherever they go,” she said. “You can treat the tumors intelligently because now you know the address of the cancer.”
The technology could be used to detect and track the 100-plus types of cancer, and could be available within five years, Moghe said. Real-time surveillance of lesions in multiple organs should lead to more accurate pre- and post-therapy monitoring of cancer.
“You can potentially determine the stage of the cancer and then figure out what’s the right approach for a particular patient,” he said.
In the future, nanoprobes could be used in any surgeries to mark tissues that surgeons want to remove, the researchers said. The probes could also be used to track the effectiveness of immunotherapy, which includes stimulating the immune system to fight cancer cells.
The Latest on: Nanoprobes
- Gold 'nanoprobes' used to track blood flow in tiny vessels on October 10, 2017 at 4:12 pm
Scientists have designed gold nanoparticles, no bigger than 100 nanometres, which can be coated and used to track blood flow in the smallest blood vessels in the body. By improving our understanding o... […]
- Scientists to explore asteroid belt with nanoprobes on September 20, 2017 at 12:46 am
A mission study by the Finnish Meteorological Institute (FMI) outlines a plan to explore an asteroid belt with nano-spacecraft, reported Popular Mechanics. The asteroid belt lies between Mars and Jupi... […]
- Novel Technique Stamps Out Nanoprobes on May 10, 2017 at 2:03 pm
One of the cornerstones of the U.S. National Nanotechnology Initiative was the establishment of nanotechnology research facilities that would be available to outside users. One of the five user facili... […]
- What it would take to probe Proxima b? on August 26, 2016 at 6:11 am
Scientists plan to do just that – through what are called nanoprobes. Here’s a Q&A about what it would take to probe Proxima b: How far is Proxima b from earth, and what could be the best way to study ... […]
- Bright future for protein nanoprobes on March 18, 2014 at 9:47 am
Researchers at Berkeley Lab’s Molecular Foundry created upconverting nanoparticles (UCNPs) from nanocrystals of sodium yttrium fluoride (NaYF4) doped with ytterbium and erbium that can be safely used ... […]
- Engineering of ultra-small diagnostic nanoprobes through oriented conjugation of single-domain antibodies and quantum dots on August 21, 2012 at 5:00 pm
Nanoparticle-based biodetection commonly employs monoclonal antibodies (mAbs) for targeting. Although several types of conjugates have been used for biomarker labeling, the large size of mAbs limits t... […]
- High tech detection of breast cancer using nanoprobes and SQUID on October 27, 2011 at 5:00 pm
Mammography saves lives by detecting very small tumors. However, it fails to find 10-25% of tumors and is unable to distinguish between benign and malignant disease. New research published in BioMed C... […]
- New Nanoprobes Go Straight to Tumor Sites on December 15, 2009 at 3:55 am
At this point, chemotherapy is one of the therapies for cancer that are used around the word. Millions of people are subjected to the drugs, which indeed have some efficiency in destroying tumor cells ... […]
- Single-cell nanoprobes on January 1, 2001 at 3:59 am
On page 764, Vo-Dinh et al. describe an antibody-based fiberoptic nanoprobe for measuring the intracellular concentration of a fluorescent molecule, benzopyrene tetrol (BPT). BPT is produced by humans ... […]
via Google News and Bing News